 United States Food and Drug Administration
"United States Food and Drug Administration" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An agency of the PUBLIC HEALTH SERVICE concerned with the overall planning, promoting, and administering of programs pertaining to maintaining standards of quality of foods, drugs, therapeutic devices, etc.
| Descriptor ID |
D014486
|
| MeSH Number(s) |
I01.409.418.750.600.650.760 N03.540.348.500.500.600.650.760
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "United States Food and Drug Administration".
Below are MeSH descriptors whose meaning is more specific than "United States Food and Drug Administration".
This graph shows the total number of publications written about "United States Food and Drug Administration" by people in this website by year, and whether "United States Food and Drug Administration" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 | | 2001 | 0 | 1 | 1 | | 2004 | 0 | 1 | 1 | | 2005 | 0 | 1 | 1 | | 2006 | 0 | 2 | 2 | | 2008 | 0 | 1 | 1 | | 2009 | 0 | 1 | 1 | | 2010 | 0 | 2 | 2 | | 2011 | 0 | 1 | 1 | | 2012 | 0 | 2 | 2 | | 2013 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "United States Food and Drug Administration" by people in Profiles.
-
Reitzel LR, Li Y, Stewart DW, Cao Y, Wetter DW, Waters AJ, Vidrine JI. Race moderates the effect of menthol cigarette use on short-term smoking abstinence. Nicotine Tob Res. 2013 May; 15(5):883-9.
-
Goyal RK, Rajan SS, Essien EJ, Sansgiry SS. Effectiveness of FDA's new over-the-counter acetaminophen warning label in improving consumer risk perception of liver damage. J Clin Pharm Ther. 2012 Dec; 37(6):681-5.
-
Kubiszyn T, Mire S, Dutt S, Papathopoulos K, Burridge AB. Significant differences in pediatric psychotropic side effects: Implications for school performance. Sch Psychol Q. 2012 Mar; 27(1):4-28.
-
Ried LD, Huston SA, Kucukarslan SN, Sogol EM, Schafermeyer KW, Sansgiry SS. Risks, benefits, and issues in creating a behind-the-counter category of medications. J Am Pharm Assoc (2003). 2011 Jan-Feb; 51(1):26-39.
-
Renshaw AA. UroVysion, urine cytology, and the College of American Pathologists: where should we go from here? Arch Pathol Lab Med. 2010 Aug; 134(8):1106-7.
-
Kamble P, Sherer J, Chen H, Aparasu R. Off-label use of second-generation antipsychotic agents among elderly nursing home residents. Psychiatr Serv. 2010 Feb; 61(2):130-6.
-
Nagar S, Mehta S, Bhatara V, Aparasu R. Health care consequences of black-box warnings for antidepressants in the United States and Canada. Res Social Adm Pharm. 2010 Mar; 6(1):78-84.
-
Chanda S, Sansgiry SS. Evaluation of facsimile cards for pharmacy-access products containing pseudoephedrine or ephedrine. J Am Pharm Assoc (2003). 2008 Jan-Feb; 48(1):52-7.
-
Murty S, Sansgiry SS. Pseudoephedrine laws in the US--are we doing enough? Ann Pharmacother. 2006 Jun; 40(6):1213-5.
-
Sherer JT. Pharmaceuticals in the environment. Am J Health Syst Pharm. 2006 Jan 15; 63(2):174-8.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|